Literature DB >> 8034295

Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.

C J Danpure1, G M Birdsey, G Rumsby, M J Lumb, P E Purdue, J Allsop.   

Abstract

The autosomal recessive disease primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the liver-specific peroxisomal enzyme alanine:glyoxylate amino-transferase (AGT). This paper concerns the identification, characterization and clinical use of an unusual discretely polymorphic tandem repeat sequence in the fourth intron of the human AGT gene (gene locus designation AGXT). In a random Caucasian population, three alleles could be clearly recognized that consisted of either 12 (type III), 17 (type II) or approximately 38 (type I) tandemly repeated copies of a highly conserved 29/32-bp sequence with frequencies of 33%, 7% and 60%, respectively. In a random Japanese population, the allelic frequencies were markedly different (i.e. 31%, 45% and 19%, respectively). In addition, a fourth allele was identified, consisting of approximately 32 repeats (type IV), with an allelic frequency of approximately 5% in Japanese. The repetitive sequence was similar to previously identified mammalian sequences with homology to the Epstein-Barr virus IR3 repetitive element involving a 12/15-bp region GCA(GGN)GGAGGAGGG within the repeat unit. This IR3-like sequence was interspersed with a 17-bp sequence with no similarity to any currently known repetitive element. The type I and type III alleles were judged to be equivalent to a previously identified TaqI polymorphism. Two polymorphisms previously shown to be associated with the peroxisome-to-mitochondrion mistargeting of AGT in PH1 (a C154-->T point substitution in exon 1 and a 74-bp duplication in intron 1) were found to segregate exclusively with the type I intron 4 polymorphism in Caucasians, but not in Japanese. The polymorphic nature of the intron 4 tandem repeats makes them of potential use in the prenatal diagnosis of PH1, especially when coupled with the exon 1 C154-->T substitution or intron 1 duplication polymorphisms. A PH1 family, in which a fetus had been predicted previously to be either normal or a carrier by AGT enzymic analysis of a fetal liver biopsy, but who had been shown to be only partially informative with respect to the C154-->T/intron 1 polymorphisms, was analysed retrospectively. The family was completely informative for the intron 4 tandem repeat polymorphism and the carrier status of the fetus was confirmed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034295     DOI: 10.1007/bf02272842

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvate aminotransferase gene.

Authors:  K Nishiyama; T Funai; R Katafuchi; F Hattori; K Onoyama; A Ichiyama
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

2.  Cloning a selected fragment from a human DNA 'fingerprint': isolation of an extremely polymorphic minisatellite.

Authors:  Z Wong; V Wilson; A J Jeffreys; S L Thein
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

3.  Clustering of hypervariable minisatellites in the proterminal regions of human autosomes.

Authors:  N J Royle; R E Clarkson; Z Wong; A J Jeffreys
Journal:  Genomics       Date:  1988-11       Impact factor: 5.736

4.  Hypervariable 'minisatellite' regions in human DNA.

Authors:  A J Jeffreys; V Wilson; S L Thein
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

5.  Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity.

Authors:  C J Danpure; P R Jennings; R W Watts
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

6.  Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon.

Authors:  Y Takada; N Kaneko; H Esumi; P E Purdue; C J Danpure
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

7.  Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.

Authors:  C J Danpure; P R Jennings
Journal:  Clin Sci (Lond)       Date:  1988-09       Impact factor: 6.124

8.  Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1.

Authors:  P J Cooper; C J Danpure; P J Wise; K M Guttridge
Journal:  J Histochem Cytochem       Date:  1988-10       Impact factor: 2.479

9.  A new micro-assay for human liver alanine: glyoxylate aminotransferase.

Authors:  J Allsop; P R Jennings; C J Danpure
Journal:  Clin Chim Acta       Date:  1987-12       Impact factor: 3.786

10.  Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes.

Authors:  M Heller; A Henderson; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

View more
  6 in total

1.  Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT).

Authors:  A C Tarn; C von Schnakenburg; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

Review 2.  What are the present possibilities for the prenatal diagnosis of primary hyperoxaluria?

Authors:  C J Danpure
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Primary hyperoxaluria type 1: a cluster of new mutations in exon 7 of the AGXT gene.

Authors:  C von Schnakenburg; G Rumsby
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

Review 4.  Molecular and cell biology of primary hyperoxaluria type 1.

Authors:  C J Danpure
Journal:  Clin Investig       Date:  1994-09

5.  Diet and the frequency of the alanine:glyoxylate aminotransferase Pro11Leu polymorphism in different human populations.

Authors:  Elizabeth F Caldwell; Lianne R Mayor; Mark G Thomas; Christopher J Danpure
Journal:  Hum Genet       Date:  2004-10-05       Impact factor: 4.132

6.  Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.

Authors:  Michael J Lumb; Graeme M Birdsey; Christopher J Danpure
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.